Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.

@article{Lebeau1994SubcutaneousHT,
  title={Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group.},
  author={Bernard Lebeau and Claude Chastang and J. M. Brechot and Florent Capron and Bertrand Dautzenberg and C Delaisements and Michel Mornet and J C Brun and J P Hurdebourcq and Etienne Lemari{\'e}},
  journal={Cancer},
  year={1994},
  volume={74 1},
  pages={38-45}
}
BACKGROUND A positive influence of anticoagulant treatment in small cell lung cancer (SCLC) has been suggested by experimental and clinical data. METHODS In a multicenter clinical trial, 277 patients with SCLC were randomized either to receive or not to receive subcutaneous heparin injections for 5 weeks at effective doses, which were monitored by blood coagulation tests. All patients received one of the two chemotherapy regimens studied in this trial, for eight courses in the case of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 87 extracted citations

Similar Papers

Loading similar papers…